SCHEMBL8482402

SCHEMBL8482402

CCCCc1cccc2c1C(C(=O)N(CC(F)(F)F)N1CCCCC1NC(=O)c1ccccc1Oc1ccccc1)c1ccccc1-2

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCR3 P51677 1/20 0.35
▸ CNR1 P21554 3/20 0.33
▸ CNR2 P34972 3/20 0.33
▸ SCN1A P35498 1/20 0.33
▸ SCN2A Q99250 1/20 0.33
▸ SCN3A Q9NY46 1/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ SLC6A9 P48067 1/20 0.32
▸ TSHR P16473 3/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ OPRM1 P35372 1/20 0.31
▸ SIGMAR1 Q99720 1/20 0.31
▸ HCRTR1 O43613 1/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ GAA P10253 1/20 0.31
▸ MAPT P10636 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ KDM5A P29375 1/20 0.30
▸ HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8717987 0.87 CCR3 (0.44) CCR3CNR1CNR2KDM4EMAPT
SCHEMBL8668024 0.87 CCR3 (0.35) CCR3SCN1ASCN2ASCN3AL3MBTL1
SCHEMBL8665520 0.86 CCR3 (0.42) CCR3L3MBTL1NPSR1KDM4EKDM5A
SCHEMBL8712541 0.85 CCR3 (0.44) CCR3L3MBTL1NPSR1KDM4EMAPT
SCHEMBL8665531 0.84 CCR3 (0.41) CCR3L3MBTL1NPSR1KDM4EKDM5A
SCHEMBL8482395 0.81 MAPT (0.38) CCR3SCN1ASCN2ASCN3AL3MBTL1
SCHEMBL8577131 0.79 GAA (0.34) L3MBTL1NPSR1TSHRALDH1A1GAA
SCHEMBL8574668 0.79 GAA (0.36) L3MBTL1NPSR1TSHRALDH1A1GAA
SCHEMBL8653118 0.77 CCR3 (0.43) CCR3CNR1CNR2L3MBTL1NPSR1
SCHEMBL8713186 0.76 DRD2 (0.36) ALDH1A1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5739135-A PREVENTING OR TREATING ATHEROSCLEROSIS, PANCREATITIS SECONDARY TO HYPERTRIGLYCERIDEMIA, HYPERGLYCEMIA, OBESITY BRISTOL-MYERS SQUIBB COMPANY (US) 1998-04-14 — — US claimed
US-5883099-A TREATMENT OF ATHERSCLEROSIS, PANCREATITIS OBESITY OR HYPERGLYCEMIA BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-16 — — US disclosed
US-5739135-A PREVENTING OR TREATING ATHEROSCLEROSIS, PANCREATITIS SECONDARY TO HYPERTRIGLYCERIDEMIA, HYPERGLYCEMIA, OBESITY BRISTOL-MYERS SQUIBB COMPANY (US) 1998-04-14 — — US disclosed
Send feedback